The NF-κB/NUAK2 signaling axis regulates pancreatic cancer progression by targeting SMAD2/3

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Nuclear factor kappa B (NF-κB) is implicated in pancreatic cancer development.
• Phosphorylation of NF-κB has been linked to NUAK2 regulation, but the precise connection is unknown.
• The role of NUAK2 in pancreatic cancer progression requires further elucidation.

Purpose of the Study:

• To investigate the regulatory relationship between NF-κB and NUAK2 in pancreatic cancer.
• To determine the functional role of NUAK2 in pancreatic cancer cell behavior.
• To explore the therapeutic potential of targeting NUAK2.

Main Methods:

• Cell proliferation, migration, and invasion assays were performed.
• Apoptosis was induced and measured.
• Western blotting and promoter binding assays were utilized to assess molecular mechanisms.
• Sensitivity to gemcitabine was evaluated.

Main Results:

• NUAK2 inhibition suppressed pancreatic cancer cell proliferation, migration, and invasion, while inducing apoptosis.
• NUAK2 overexpression counteracted apoptosis and reversed NF-κB inhibitor effects.
• NF-κB directly regulated NUAK2 transcription via promoter binding.
• NUAK2 knockdown reduced SMAD2/3 phosphorylation and SMAD4 nuclear translocation, impacting FAK signaling.
• NUAK2 inhibition increased sensitivity to gemcitabine.

Conclusions:

• NF-κB transcriptionally controls NUAK2 expression in pancreatic cancer.
• NUAK2 plays a critical role in promoting pancreatic cancer cell survival and progression.
• Targeting NUAK2 represents a promising therapeutic avenue for pancreatic cancer, potentially enhancing gemcitabine efficacy.